Cargando…

Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes

SIMPLE SUMMARY: Different cells present in the tumor microenvironment can deeply influence both cancer spreading and the success of therapy in solid tumors, including colorectal carcinoma (CRC). In particular, tumor-associated fibroblasts (TAF) exert potent immunosuppressive effects leading to the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez, Jordi Leonardo Castrillo, Benelli, Roberto, Costa, Delfina, Campioli, Alessio, Tavella, Sara, Zocchi, Maria Raffaella, Poggi, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913507/ https://www.ncbi.nlm.nih.gov/pubmed/36765569 http://dx.doi.org/10.3390/cancers15030610

Ejemplares similares

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab
por: Benelli, Roberto, et al.
Publicado: (2022)

Three-Dimensional Culture Models to Study Innate Anti-Tumor Immune Response: Advantages and Disadvantages
por: Poggi, Alessandro, et al.
Publicado: (2021)

Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer
por: Di Mascolo, Daniele, et al.
Publicado: (2019)

Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures
por: Varesano, Serena, et al.
Publicado: (2018)

Corrigendum: Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures
por: Varesano, Serena, et al.
Publicado: (2018)

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts
por: Costa, Delfina, et al.
Publicado: (2018)

Dosing of zoledronic acid with its anti-tumor effects in breast cancer
por: Zhao, Xinmin, et al.
Publicado: (2015)

Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment
por: Poggi, Alessandro, et al.
Publicado: (2012)

The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent
por: Cheng, Yinwen, et al.
Publicado: (2021)

Human Gut-Associated Natural Killer Cells in Health and Disease
por: Poggi, Alessandro, et al.
Publicado: (2019)

How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
por: Poggi, Alessandro, et al.
Publicado: (2018)

Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis
por: Akoury, Elie, et al.
Publicado: (2019)

Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
por: Poggi, Alessandro, et al.
Publicado: (2018)

Three-Dimensional (3D) Culture Models in Cancer Investigation, Drug Testing and Immune Response Evaluation
por: Benelli, Roberto, et al.
Publicado: (2020)

Evolution of 3D Cultures: Toward Tailored Preclinical Models
por: Benelli, Roberto, et al.
Publicado: (2023)

Immune Checkpoint Receptor/Ligand Expression and Chemotherapy in Colorectal Cancer
por: Benelli, Roberto, et al.
Publicado: (2023)

Maspin expression in prostate tumor elicits host anti-tumor immunity
por: Dzinic, Sijana H., et al.
Publicado: (2014)

The anti-tumour effects of zoledronic acid
por: Zekri, Jamal, et al.
Publicado: (2014)

Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models
por: Matsuo, Teppei, et al.
Publicado: (2011)

Inhibition of ITGB1 enhance the anti-tumor effect of cetuximab in colorectal cancer cell
por: Yang, Xiaohui, et al.
Publicado: (2020)

Mesenchymal stromal cells as regulators of anti-tumour immune response
por: Poggi, Alessandro, et al.
Publicado: (2015)

Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer
por: Cai, Xin-Jun, et al.
Publicado: (2017)

The effect of near-infrared fluorescence conjugation on the anti-cancer potential of cetuximab
por: Yun, Ji Young, et al.
Publicado: (2018)

Lysyl-Oxidase Dependent Extracellular Matrix Stiffness in Hodgkin Lymphomas: Mechanical and Topographical Evidence
por: Alfano, Massimo, et al.
Publicado: (2022)

Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy
por: Zocchi, Maria Raffaella, et al.
Publicado: (2020)

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma
por: KURAI, JUN, et al.
Publicado: (2012)

Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-Leukemic Reactivity in Patients with Chronic Myelogenous Leukemia
por: Catellani, Silvia, et al.
Publicado: (2011)

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2019)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
por: Veluchamy, John Pradeep, et al.
Publicado: (2016)

Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels
por: Okamoto, Shinya, et al.
Publicado: (2013)

Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells
por: Wang, Sheng, et al.
Publicado: (2023)

Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid
por: Fenn, J, et al.
Publicado: (2022)

Multiplexed activation of endogenous genes by CRISPRa elicits potent anti-tumor immunity
por: Wang, Guangchuan, et al.
Publicado: (2019)

PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosis
por: Carter, M J, et al.
Publicado: (2017)

Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021)

Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity
por: Chen, Lu, et al.
Publicado: (2013)

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
por: Huang, Jianmei, et al.
Publicado: (2022)

Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status
por: Kato, Junko, et al.
Publicado: (2016)

Efficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case report
por: Tokumaru, Yoshihisa, et al.
Publicado: (2019)

Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
por: Mortara, Lorenzo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fqo0shmkqdn6j6b3hqbht2ag4i